Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study
暂无分享,去创建一个
James R. Brown | J. Wedzicha | A. Brookes | Dave Singh | U. Kolsum | C. Brightling | B. Miller | R. Tal-Singer | G. Donaldson | P. Barnes | L. Donnelly | Zhang Wang | S. Van Horn | L. George | A. Webb | A. Mackay | Richa Singh | J. Allinson | B. Barker | K. Belchamber | Lynn Tomsho
[1] J. Curtis,et al. Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions. , 2017, Translational research : the journal of laboratory and clinical medicine.
[2] James R. Brown,et al. Lung microbiome dynamics in COPD exacerbations , 2016, European Respiratory Journal.
[3] A. Agustí,et al. Heterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposal. , 2015, The Lancet. Respiratory medicine.
[4] Rob Knight,et al. Temporal variability is a personalized feature of the human microbiome , 2014, Genome Biology.
[5] B. Marsland,et al. Host–microorganism interactions in lung diseases , 2014, Nature Reviews Immunology.
[6] Paul Turner,et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses , 2014, BMC Biology.
[7] F. Martinez,et al. The role of the microbiome in exacerbations of chronic lung diseases , 2014, The Lancet.
[8] H. Boushey,et al. Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease , 2014, Journal of Clinical Microbiology.
[9] Jiajie Zhang,et al. PEAR: a fast and accurate Illumina Paired-End reAd mergeR , 2013, Bioinform..
[10] J. Hammermann,et al. Neutrophil elastase-mediated increase in airway temperature during inflammation. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[11] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[12] V. Pérez-Brocal,et al. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa , 2014, European Journal of Clinical Microbiology & Infectious Diseases.
[13] S. Johnston,et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.
[14] Jesse R. Zaneveld,et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.
[15] J. Wedzicha,et al. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease , 2013, BMC Medicine.
[16] H. Dienemann,et al. Analysis of the Airway Microbiota of Healthy Individuals and Patients with Chronic Obstructive Pulmonary Disease by T-RFLP and Clone Sequencing , 2013, PloS one.
[17] 药学. International Conference on Harmonisation of Technical Requirements , 2013 .
[18] Pelin Yilmaz,et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..
[19] Richard E. Isaacson,et al. The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease , 2012, PloS one.
[20] Christopher E Brightling,et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. , 2012, American journal of respiratory and critical care medicine.
[21] William A. Walters,et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.
[22] Eric P. Nawrocki,et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea , 2011, The ISME Journal.
[23] J. Maurer. Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers , 2012 .
[24] Rob Knight,et al. UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..
[25] J. Curtis,et al. Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD , 2011, PloS one.
[26] Robert C. Edgar,et al. BIOINFORMATICS APPLICATIONS NOTE , 2001 .
[27] Mm Jones. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care , 2010 .
[28] J. Wedzicha,et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.
[29] William A. Walters,et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample , 2010, Proceedings of the National Academy of Sciences.
[30] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[31] Eoin L. Brodie,et al. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. , 2010, Omics : a journal of integrative biology.
[32] Lior Pachter,et al. Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.
[33] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[34] O. Uzun,et al. Role of bacteria in acute exacerbations of chronic obstructive pulmonary disease , 2008, International journal of chronic obstructive pulmonary disease.
[35] S. Bojesen,et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[36] I. Douglas,et al. Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? , 2006, Proceedings of the American Thoracic Society.
[37] C. D. Mathers,et al. Chronic obstructive pulmonary disease: current burden and future projections , 2006, European Respiratory Journal.
[38] Johan Trygg,et al. Multi- and Megavariate Data Analysis : Part II: Advanced Applications and Method Extensions , 2006 .
[39] A. Anzueto,et al. Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2003 .
[40] Richard C Boucher,et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.
[41] T. Murphy,et al. Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review , 2001, Clinical Microbiology Reviews.
[42] R. Rodríguez-Roisín,et al. Toward a consensus definition for COPD exacerbations. , 2000, Chest.
[43] M. Miravitlles,et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. , 1999, Chest.
[44] R. Rodríguez-Roisín,et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.
[45] J. Ruiz,et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. , 1995, American journal of respiratory and critical care medicine.
[46] P. Ball. Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations , 1995, Chest.
[47] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[48] N. Anthonisen,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.
[49] B. Burrows,et al. CHRONIC OBSTRUCTIVE PULMONARY EMPHYSEMA. , 1964, Biochemical clinics.
[50] F. C. Lowell,et al. Chronic obstructive pulmonary emphysema; a disease of smokers. , 1956, Annals of internal medicine.